Kenneth M. Bahrt
2017 - Outlook Therapeutics
In 2017, Kenneth M. Bahrt earned a total compensation of $629.7K as Chief Medical Officer at Outlook Therapeutics, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $108,209 |
| Other | $21,469 |
| Total | $629,678 |
Bahrt received $400K in salary, accounting for 64% of the total pay in 2017.
Bahrt also received $100K in bonus, $108.2K in stock awards and $21.5K in other compensation.
Rankings
In 2017, Kenneth M. Bahrt's compensation ranked 11,019th out of 14,666 executives tracked by ExecPay. In other words, Bahrt earned more than 24.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,019 out of 14,666 | 25th |
Division Manufacturing | 4,313 out of 5,772 | 25th |
Major group Chemicals And Allied Products | 1,562 out of 2,075 | 25th |
Industry group Drugs | 1,282 out of 1,731 | 26th |
Industry Biological Products, Except Diagnostic Substances | 231 out of 313 | 26th |
Source: SEC filing on August 17, 2018.
Bahrt's colleagues
We found two more compensation records of executives who worked with Kenneth M. Bahrt at Outlook Therapeutics in 2017.